Product NDC: | 63739-366 |
Proprietary Name: | Labetalol HCl |
Non Proprietary Name: | Labetalol HCl |
Active Ingredient(s): | 200 mg/1 & nbsp; Labetalol HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-366 |
Labeler Name: | McKesson Packaging Services a business unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075113 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061115 |
Package NDC: | 63739-366-10 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-366-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 63739-366-10 |
Proprietary Name | Labetalol HCl |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-366-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 63739-366 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Labetalol HCl |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20061115 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services a business unit of McKesson Corporation |
Substance Name | LABETALOL HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |